Royal Bank of Canada’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-225
| Closed | -$1K | – | 8298 |
|
|
2022
Q2 | $1K | Hold |
225
| – | – | ﹤0.01% | 7304 |
|
|
2022
Q1 | $1K | Hold |
225
| – | – | ﹤0.01% | 7687 |
|
|
2021
Q4 | $1K | Sell |
225
-50
| -18% | -$208 | ﹤0.01% | 7604 |
|
|
2021
Q3 | $1K | Sell |
275
-4,135
| -94% | -$16.4K | ﹤0.01% | 7585 |
|
|
2021
Q2 | $19K | Buy |
4,410
+2,777
| +170% | +$11.9K | ﹤0.01% | 6605 |
|
|
2021
Q1 | $7K | Sell |
1,633
-121
| -7% | -$667 | ﹤0.01% | 6977 |
|
|
2020
Q4 | $7K | Buy |
1,754
+1,484
| +550% | +$6.34K | ﹤0.01% | 6567 |
|
|
2020
Q3 | $1K | Buy |
270
+225
| +500% | +$932 | ﹤0.01% | 6561 |
|
|
2020
Q2 | $0 | Sell |
45
-15,563
| -100% | -$94.8K | ﹤0.01% | 7228 |
|
|
2020
Q1 | $65K | Sell |
15,608
-4,392
| -22% | -$27.7K | ﹤0.01% | 5033 |
|
|
2019
Q4 | $79K | Buy |
20,000
+18,000
| +900% | +$106K | ﹤0.01% | 5215 |
|
|
2019
Q3 | $18K | Sell |
2,000
-400
| -17% | -$3.78K | ﹤0.01% | 5557 |
|
|
2019
Q2 | $23K | Buy |
+2,400
| New | +$18.1K | ﹤0.01% | 5665 |
|
|
2018
Q4 | – | Sell |
-582
| Closed | -$12K | – | 7606 |
|
|
2018
Q3 | $12K | Buy |
582
+429
| +280% | +$11.2K | ﹤0.01% | 5930 |
|
|
2018
Q2 | $4K | Sell |
153
-2,949
| -95% | -$91K | ﹤0.01% | 6139 |
|
|
2018
Q1 | $93K | Buy |
3,102
+2,792
| +901% | +$90K | ﹤0.01% | 4740 |
|
|
2017
Q4 | $10K | Sell |
310
-2,143
| -87% | -$70K | ﹤0.01% | 5888 |
|
|
2017
Q3 | $86K | Buy |
2,453
+2,303
| +1,535% | +$74.1K | ﹤0.01% | 5120 |
|
|
2017
Q2 | $5K | Sell |
150
-612
| -80% | -$17.5K | ﹤0.01% | 6089 |
|
|
2017
Q1 | $22K | Sell |
762
-187
| -20% | -$4.77K | ﹤0.01% | 5591 |
|
|
2016
Q4 | $16K | Buy |
949
+96
| +11% | +$1.84K | ﹤0.01% | 5907 |
|
|
2016
Q3 | $20K | Sell |
853
-247
| -22% | -$4.65K | ﹤0.01% | 5565 |
|
|
2016
Q2 | $18K | Hold |
1,100
| – | – | ﹤0.01% | 5565 |
|
|
2016
Q1 | $23K | Hold |
1,100
| – | – | ﹤0.01% | 5443 |
|
|
2015
Q4 | $30K | Buy |
1,100
+496
| +82% | +$13.5K | ﹤0.01% | 5559 |
|
|
2015
Q3 | $17K | Sell |
604
-2,718
| -82% | -$85.6K | ﹤0.01% | 5652 |
|
|
2015
Q2 | $82K | Buy |
3,322
+822
| +33% | +$16.9K | ﹤0.01% | 4942 |
|
|
2015
Q1 | $46K | Buy |
+2,500
| New | +$50.7K | ﹤0.01% | 5015 |
|
Royal Bank of Canada's LJPC Position: Q3 2022 in Review
Royal Bank of Canada sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 225 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in LJPC in Q1 2015 and held it in 28 quarters. The position peaked at $93K in Q1 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Royal Bank of Canada reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Royal Bank of Canada sold 225 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $1K.
- Royal Bank of Canada first reported a position in La Jolla Pharmaceutical Company in Q1 2015 and held it in 28 quarters.
- Royal Bank of Canada's La Jolla Pharmaceutical Company position peaked at $93K in Q1 2018.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.